Scientists have developed a novel model known as the PREDICT Breast model, which may reduce the need for chemotherapy in up to 38% of breast cancer patients who would have previously been advised to undergo the treatment. The latest version of this model incorporates recent breast cancer survival data and evaluates the benefits and harms of chemotherapy and radiotherapy. PREDICT Breast model was first launched in 2010 and then continuously updated.
It is currently used worldwide by over 40,000 clinicians and patients each month to estimate long-term survival and the benefits of various therapies. Scientists have emphasized that the model's data shows chemotherapy can be safely avoided for many women with breast cancer, thus sparing them from significant physical side effects. They also highlighted that the model's success is based on high-quality data and traditional statistical methods…
